文献速递其他结缔组织病

系统性硬化症患者肾衰竭风险:一项全国性人群研究

Risk of kidney failure in patients with systemic sclerosis: a nationwide population-based study.
PubMed 文献 · RMD Open · 2023-01-01

该研究利用韩国国民健康保险服务数据库,纳入2010至2017年间系统性硬化症(SSc)患者2591例及按年龄和性别1:5匹配的对照12955例,随访至2019年。结果显示SSc患者肾衰竭发生率为2.88/1000人年,对照组为0.35/1000人年,校正后风险比为7.244(95%CI 4.256至12.329),表明SSc患者肾衰竭风险仍显著高于一般人群。

要点

  • SSc患者肾衰竭发生率为2.88/1000人年,对照组为0.35/1000人年。
  • 校正后SSc患者肾衰竭风险显著高于对照(aHR=7.244,95%CI 4.256至12.329)。
  • 2014至2017年诊断SSc者效应量更大(aHR=9.754,95%CI 3.254至29.235)。

核心结论

  • SSc患者肾衰竭风险仍高于一般人群。

研究设计与样本

  • 全国性人群研究,使用韩国国民健康保险服务数据库,纳入2010至2017年SSc患者2591例及1:5年龄性别匹配对照12955例,随访至2019年。

主要发现

  • 随访5.2±2.6年,SSc患者肾衰竭发生率为2.88/1000人年,对照组为0.35/1000人年。
  • SSc患者肾衰竭风险显著高于对照(aHR=7.244,95%CI 4.256至12.329)。
  • 2014至2017年诊断SSc者肾衰竭风险aHR=9.754(95%CI 3.254至29.235),2010年前诊断者为aHR=6.568(95%CI 2.711至15.571),2010至2013年诊断者为aHR=6.553(95%CI 2.721至15.781)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Data from a decade ago have shown that patients with systemic sclerosis (SSc) have a higher risk of kidney failure than the general population. However, as the incidence of kidney failure due to SSc has been declining, the comparative risk of kidney failure between patients with SSc and the general population could have changed over time. We investigated the risk of kidney failure in patients with SSc compared with the general population, up to more recent years. METHODS: This was a nationwide population-based study using the Korean National Health Insurance Service database. Patients with claims data for SSc between 2010 and 2017 (n=2591) and 1:5 age-matched and sex-matched controls (n=12 955) were selected. The index date was the earliest date of claim for SSc between 2010 and 2017. The follow-up duration was from the index date to 2019. The adjusted HRs (aHRs) and 95% CI for kidney failure were estimated using multivariable Cox proportional hazard models. RESULTS: Over 5.2±2.6 years, the incidence rates of kidney failure in patients with SSc and controls were 2.88 and 0.35 per 1000 person-years, respectively. Patients with SSc had a significantly higher risk of kidney failure than controls (aHR=7.244, 95% CI=4.256 to 12.329). The effect size was larger in patients diagnosed with SSc between 2014 and 2017 (aHR=9.754, 95% CI=3.254 to 29.235) than in those diagnosed before 2010 (aHR=6.568, 95% CI=2.711 to 15.571) or between 2010 and 2013 (aHR=6.553, 95% CI=2.721 to 15.781). CONCLUSION: The risk of kidney failure remains higher in patients with SSc than in the general population.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Kwon OC, Han K, Park MC, et al. Risk of kidney failure in patients with systemic sclerosis: a nationwide population-based study. RMD Open. 2023. PMID: 37945288. doi:10.1136/rmdopen-2023-003490

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。